SEBI Likely To Reopen Insider Trading Case Against Sun Pharma
Employees enter the Sun Pharmaceutical Industries Ltd. corporate office in the Andheri suburb of Mumbai, India (Photographer: Amit Madheshiya/Bloomberg)

SEBI Likely To Reopen Insider Trading Case Against Sun Pharma

Bookmark
The Securities and Exchange Board of India is likely to reopen an insider trading case against Sun Pharmaceutical Industries Ltd. as well as probe alleged lapses by some of its promoters and other ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.